Evidence map›Paper›PMID 35844539›Full record

ReviewFrontiers in immunology2022

The Role of Intestinal Mucosal Barrier in Autoimmune Disease: A Potential Target.

Jia An, Yuqing Liu, Yiqi Wang, Ru Fan, Xiaorong Hu, Fen Zhang, Jinhua Yang, Junwei Chen

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 5 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 5 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. TibetanNutrients · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. GUTAID: a curated database linking gut microbial antigens to autoimmune mechanisms.Database : the journal of biological databases and curation · 2026
    Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jia AnDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Yuqing LiuDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Yiqi WangDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Ru FanDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Xiaorong HuDepartment of Microbiology and Immunology, Shanxi Medical University, Taiyuan, China.
Fen ZhangDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Jinhua YangDepartment of Internal Medicine, Central Hospital of Xinghualing District, Taiyuan, China.
Junwei ChenDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Shanxi Medical University · CNSecond Hospital of Shanxi Medical University · CNTaiyuan Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune diseases are a series of diseases involving multiple tissues and organs, characterized by the over production of abnormal multiple antibodies. Although most studies support that the impaired immune balance participates in the development of autoimmune diseases, the specific pathogenesis of it is not fully understood. Intestinal immunity, especially the intestinal mucosal barrier has become a research hotspot, which is considered to be an upstream mechanism leading to the impaired immune balance. As an important defense barrier, the intestinal mucosal barrier regulates and maintains the homeostasis of internal environment. Once the intestinal barrier function is impaired under the effect of multiple factors, it will destroy the immune homeostasis, trigger inflammatory response, and participate in the development of autoimmune diseases in the final. However, the mechanism of the intestinal mucosal barrier how to regulate the homeostasis and inflammation is not clear. Some studies suggest that it maintains the balance of immune homeostasis through the zonulin pathway, intestinal microbiome, and Toll-like receptor signaling pathway. Our review focused on the composition and the function of the intestinal mucosal barrier to describe the research progress of it in regulating the immune homeostasis and inflammation, and also pointed that the intestinal mucosal barrier was the potential targets in the treatment of autoimmune diseases.

Indexed as

Autoimmune DiseasesGastrointestinal MicrobiomeHumansInflammationIntestinal MucosaIntestinesautoimmune diseasesintestinal microbiomeintestinal mucosal barriertoll-like receptors signal pathwayzonulin pathway

Identifiers

PMID35844539
PMCPMC9284064
OpenAlexW4283763451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.